Anand Rathi: Neogen Chemicals Posts Mixed Q2 Performance, Outlook Strong

Neogen Chemicals’ revenue, ebitda and net profit are now estimated to grow at CAGR of 32%, 34% and 49%, respectively, over FY21-23

Anand Rathi

12 Nov 2020, 04:42 PM IST

An employee holds a glass flask in a research laboratory. (Photographer: Krisztian Bocsi/Bloomberg)

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

Anand Rathi: Neogen Chemicals Posts Mixed Q2 Performance, Outlook Strong

Neogen Chemicals’ revenue, ebitda and net profit are now estimated to grow at CAGR of 32%, 34% and 49%, respectively, over FY21-23

Choose a plan